The microtubule-affecting drug paclitaxel has antiangiogenic activity

Clinical Cancer Research

Volumn 2, Issue 11, 1996, Pages 1843-1849

  Belotti, Dorina ^a   Vergani, Veronica ^a   Drudis, Teresa ^b   Borsotti, Patrizia ^a   Pitelli, Maria Rosa ^c   Viale, Giuseppe ^b   Giavazzi, Raffaella ^a   Taraboletti, Giulia ^a  

^a MARIO NEGRI INST PHARMACOL RES   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c SAN GERARDO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; CISPLATIN; MATRIGEL; PACLITAXEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CHEMOTHERAPY; CELL MIGRATION; CONTROLLED STUDY; ENDOTHELIUM CELL; GROWTH INHIBITION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL MOVEMENT; CELLS, CULTURED; CISPLATIN; COLLAGEN; DRUG COMBINATIONS; ENDOTHELIUM, VASCULAR; LAMININ; MALE; MICE; MICE, INBRED C57BL; MICROTUBULES; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; PACLITAXEL; PROTEOGLYCANS;

EID: 0029802685     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Auerbach, W., and Auerbach, R. Angiogenesis inhibition: a review. Pharmacol. Ther., 63: 265-311, 1994.
2. Selden, S. C., III, Rabinovitch, P. S., and Schwartz, S M. Effects of cytoskeletal disrupting agents on replication of bovine endothelium. J. Cell Physiol., 108: 195-211, 1981.
3. Ettenson, D. S., and Gotlieb, A. I. Microsomes, microtubules, and microfilaments in the reendothelialization and remodeling of double-sided in vitro wounds. Lab Invest., 66: 722-733, 1992
4. Jordan, M. A., Toso, R. J., Thrower, D., and Wilson, L. Mechanism of mitotic block and inhibition of cell proliferation by Taxol at low concentration Proc. Natl. Acad. Sci. USA, 90: 9552-9556, 1993.
5. Rowinsky, E. K., and Donehower, R. C Paclitaxel (Taxol). N. Engl. J. Med., 332: 1004-1014, 1995.
6. Schiff, P. B., and Horwitz, S. B. Taxol stabilizes microtubules in mouse fibroblast cells. Proc. Natl. Acad. Sci. USA, 77: 1561-1565, 1980.
7. Verschueren, H., Dewit, J., De Braekeleer, J., Schirrmacher, V., and De Baetsleier, P. Motility and invasive potency of murine T-lymphoma cells: effect of microtubule inhibitors. Cell Biol. Int., 18: 11-19, 1994.
8. Stearns, M. E., and Wang, M Taxol blocks processes essential for prostate tumor cell (PC-3 ML) invasion and metastases. Cancer Res., 52: 3776-3781, 1992.
9. Stracke, M. L., Soroush, M., Liotta, L. A., and Schiffmann, E. Cytoskeletal agents inhibit motility and adherence of human tumor cells. Kidney Int., 43: 151-157, 1993
10. Taraboletti, G , Belotti, D., Dejana, E., Mantovani, A., and Giavazzi, R Endothelial cell migration and invasiveness are induced by a soluble factor produced by murine endothelioma cells transformed by polyoma virus middle T oncogene. Cancer Res., 53: 3812-3816, 1993.
11. Passaniti, A , Taylor, R. M., Pili, R , Guo, Y., Long, P. V., Haney, J. A., Pauly, R. R., Grant, D. S., and Martin, G. R. A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. Lab. Invest., 67: 519-528, 1992.
12. Taraboletti, G., Garofalo, A., Belotti, D., Drudis, T , Borsotti, P., Scanziani, E., Brown, P. D , and Giavazzi, R. Inhibition of angiogenesis and murine hemangioma growth by batimastat, a synthetic inhibitor of matrix metalloproteinases J. Natl. Cancer Inst., 87: 293-298, 1995.
13. Brown, P. D., Levy, A T., Margulies, I. M. K., Liotta, L. A., and Stetler-Stevenson. W. G. Independent expression and cellular processing of M, 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines Cancer Res., 50: 6184-6191, 1990.
14. Thompson, E. W., Nakamura, S., Shima, T. B., Melchiori, A., Martin, G R., Salahuddin, S. Z., Gallo, R. C., and Albini, A. Supernatants of acquired immunodeficiency syndrome-related Kaposi's sarcoma cells induce endothelial cell chemotaxis and invasiveness. Cancer Res., 51: 2670-2676, 1991.
15. Mignatti, P., Tsuboi, R., Robbins, E., and Rifkin, D. B. In vitro angiogenesis on the human amniotic membrane: requirement for basic fibroblast growth factor-induced proteinases J. Cell Biol., 108: 671-682, 1989.
16. Folkman, J., and Shing, Y. Angiogenesis, J. Biol Chem., 267: 10931-10934, 1992,
17. Seville, M. W , Lietzau, J., Pluda, J. M., Feuerstein, I., Odom, J., Wilson, W. H., Humphrey, R. W., Feigal, E., Steinberg, S. M., Broder, S., and Yarchoan, R. Treatment of HIV-associated Kaposi's sarcoma with paclitaxel. Lancet, 346: 26-28, 1995.
18. Rose, W. C. Taxol: a review of its preclinical in vivo antitumor activity. Anti-Cancer Drugs, 3: 311-321, 1992.
19. Nicoletti, M. I., Lucchini, V., Massazza, G., Abbott, B. J., D'Incalci, M., and Giavazzi, R. Antitumor activity of Taxol (NSC-125973) in human ovarian carcinomas growing in the peritoneal cavity of nude mice. Ann. Oncol. 4: 151-155, 1993.
20. Prestayko, A W., D'Aoust, J C., Issell, B. F., and Crooke, S T. Cisplatin (cis-diamminedichloroplatinum II). Cancer Treat. Rev., 6: 17-39, 1979.
21. Lee, K. Influence of chemotherapeutic agents on the proliferation of capillary endothelial cells and tumor angiogenesis in murine bladder cancer Int. J. Oncol., 6: 1021-1026, 1995
22. Yamamoto, T., Sudo, K., and Fujita, T. Significant inhibition of endothelial cell growth in tumoi vasculature by an angiogenesis inhibitor. TNP-470 (AGM-1470). Anticancer Res., 14: 1-4, 1994
23. Coomber, B. L., and Gotlieb, A. I. In vitro endothelial wound repair. Interaction of cell migration and proliferation Arteriosclerosis, 10: 215-222, 1990
24. Dordunoo, S. K., Jackson, J. K., Arsenault, L. A., Oktaba, A. M. C., Hunter, W. L., and Burt, H. M Taxol encapsulation in poly(ε-caprolactone) microspheres. Cancer Chemother. Pharmacol., 36: 279-282, 1995